Clinical Trial Update: MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery [NA]

View source ↗

Summary

A completed clinical trial at Duke University compared MiraLAX to placebo for preventing constipation after urogynecologic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

Sponsor: Duke University | Conditions: Post Procedural Constipation | NA | Status: COMPLETED